The Skin Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Vitiligo2 trials
• Melanoma1 trial
• Psoriasis1 trial

Phase

• Phase 36 trials

Status

• Completed3 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Pfizer2 trials
• Amgen1 trial
• Bristol-Myers Squibb1 trial
• Eli Lilly and Company1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

  Contact: John Frew, Site 0271

• Recruiting

  Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

  NCT06585410· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

  NCT06163326· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05633355· Phase 3· Amgen· Source

• Completed

  A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

  NCT05583526· Phase 3· Pfizer· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source